BusinessHemispherx Biopharma to Present Data on the Activity of Ampligen® Against Cancer at CHI’s 4th Annual Immuno-Oncology Summit, August 29 through September 2, 2016 in Boston, MABy Nasdaq OMXAug 29, 2016, 12:30 PM UTC
BusinessPetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA SubmissionBy Nasdaq OMXAug 25, 2016, 12:43 PM UTC
BusinessImmune Design Presents New Preclinical Data on Advances of Two Separate Intratumoral Approaches at the American Association for Cancer Research (AACR) Annual Meeting 2016By Nasdaq OMXApr 20, 2016, 1:00 PM UTC
BusinessPreclinical Data Presented at American Association for Cancer Research (AACR) Annual Meeting Demonstrate Enhanced Therapeutic Benefit of Combining a PS-Targeting Antibody With Anti-PD-1 Therapy in Models of Triple Negative Breast Cancer (TNBC)By Nasdaq OMXApr 20, 2016, 12:05 PM UTC
BusinessAREVA Med Inaugurates Second Lead-212 Production FacilityBy Nasdaq OMXApr 13, 2016, 7:23 PM UTC
BusinessFluidigm Announces New Integrated Fluidic Circuits for Single-Cell Genomics on the C1 SystemBy Nasdaq OMXApr 12, 2016, 12:44 PM UTC
